💊 Drugs A-Z 🧬 Targets 🛠 Tools 📚 Guides
All Drugs Drug Classes Therapeutic Areas Side Effects
Guides Glossary Timeline
Comparisons Drug Journeys Drug Families
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Telmisartan

CHEMBL1017 Phase 4 Approved Small molecule
Half-Life
24 hours
Bioavailability
—
Protein Binding
—
Molecular Weight
514.6 g/mol
LogP
6.9
Phase
4

This medication belongs to the angiotensin receptor blocker (ARB) class and is used to treat high blood pressure and to reduce the risk of heart attack and stroke in high-risk patients. It works by blocking the action of a hormone called angiotensin II, which normally tightens blood vessels. It is taken once daily and is generally well tolerated.

Molecular Weight

514.6230 g/mol

LogP

6.90

TPSA

72.90 Ų

Lipinski RO5

Fail

Therapeutic Areas

Alzheimer's Disease Atrial Fibrillation Breast Cancer Cardiovascular Disease Chronic Kidney Disease Heart Failure Hyperlipidemia Hypertension Non-Alcoholic Fatty Liver Disease Obesity Ovarian Cancer Parkinson's Disease Prostate Cancer Schizophrenia Stroke Type 2 Diabetes

Drug Classes

C — C - Cardiovascular System

Mechanism of Action

Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics (PK)

Half-Life 24 hours

Pharmacodynamics (PD)

Mechanism

Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

2D Structure

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1

                

                

                
                

                    
InChI

                    
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

                

                

                

                    
                    

                        
Molecular Formula

                        
C33H30N4O2

                    

                    
                    

                        
HBD / HBA

                        
1 / 4

                    

                    
                    

                        
Rotatable Bonds

                        
7

                    

                    
                    
                    

                        
Heavy Atoms

                        
39

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Frequently Asked Questions

                

                    
                    

                        
                        

                            
This medication belongs to the angiotensin receptor blocker (ARB) class and is used to treat high blood pressure and to reduce the risk of heart attack and stroke in high-risk patients. It works by blocking the action of a hormone called angiotensin II, which normally tightens blood vessels. It is taken once daily and is generally well tolerated.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

                        

                    

                    

                    
                    

                        
                        

                            
Key pharmacokinetic parameters for Telmisartan: Half-life: 24 hours.

                        

                    

                    

                    

                        
                        

                            
Yes, Telmisartan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            
            

                
Related Drugs


                
                

                    
Same Drug Class

                    

                        
                        
                            Amlodipine
                            Small molecule
                        
                        
                        
                            Atenolol
                            Small molecule
                        
                        
                        
                            Atorvastatin
                            Small molecule
                        
                        
                        
                            Bisoprolol
                            Small molecule
                        
                        
                    

                

                

                
            

            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1017.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 65999.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Medical Disclaimer

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.